Associate Chief
Massachusetts General Hospital
Boston, Massachusetts, United States
Dr. Shenoy is an infectious diseases physician at Massachusetts General Hospital (MGH) where she is Associate Chief of the Infection Control Unit. She is an Associate Professor of Medicine at Harvard Medical School and is trained as a health economist. Her research has evaluated the clinical, operational and economic impact of competing infection control strategies for multi-drug resistant pathogens and hospital acquired infections through clinical studies and mathematical modeling, has leveraged electronic health records for infection control surveillance, and applied machine-learning techniques to create risk prediction models for communicable diseases. She has investigated and published on detection and prevention of nosocomial infections, and has collaborated on research and implementation of interventions to improve antibiotic use in patients with history of antibiotic allergies.
Dr. Shenoy is Medical Director of the Regional Emerging Special Pathogens Treatment Center at MGH, one of 10 facilities supported by the US Department of Health and Human Services as part of the regional treatment network for emerging pathogens. She has served as the Infectious Diseases and Infection Control advisor to MGH and advisor to the MassGeneral Brigham for the COVID-19 response. She has published and lectured on infection prevention approaches for SARS-CoV-2, the role of universal masking in healthcare settings and in the community, evaluation and management of healthcare workers infected with COVID-19, on optimizing evaluation and isolation of patients with suspected and confirmed COVID-19 in healthcare settings, and COVID-19 vaccine deployment among healthcare personnel.
Dr. Shenoy is a Fellow in both the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). She has served on the Guidelines Committee of SHEA and currently a member of SHEA’s Public Policy and Government Affairs Committee and co-chair of the Sterilization and High-Level Disinfection guidelines committee. An active member of IDSA, she previously served on the IDSA Antimicrobial Resistance Committee.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Friday, October 13, 2023
2:15 PM – 2:30 PM US ET
Friday, October 13, 2023
3:15 PM – 3:27 PM US ET
Saturday, October 14, 2023
2:33 PM – 2:45 PM US ET